{
    "Trade/Device Name(s)": [
        "Sofia\u00ae hCG FIA"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K131166",
    "Predicate Device Reference 510(k) Number(s)": [
        "K973858"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI"
    ],
    "Summary Letter Date": "August 2, 2013",
    "Summary Letter Received Date": "July 3, 2013",
    "Submission Date": "July 1, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "POCT"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Sofia Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cassette",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Sofia\u00ae hCG FIA immunofluorescence-based lateral flow assay for qualitative detection of hCG in urine on Sofia Analyzer",
    "Indications for Use Summary": "Intended for the qualitative detection of human Chorionic Gonadotropin (hCG) in urine specimens to aid early detection of pregnancy, for prescription use including point-of-care sites",
    "fda_folder": "Clinical Chemistry"
}